ImmunityBio's stock has risen sharply this year. Read more on whether investors should look closely at shares or avoid the ...

Pancreatic cancer is the fourth leading cause of cancer death in the US, with over 35,000 deaths reported in 2009. 1 In 1997, gemcitabine became the standard of care for advanced disease and since ...

Patients with muscle-invasive bladder cancer who were treated with presurgical chemotherapy may have a 55% lower risk of ...

US-based biotechnology company Trishula Therapeutics has reported positive results from its Phase I clinical trial of TTX-030 ...

Advanced breast cancer is also called secondary breast cancer. You usually have gemcitabine and paclitaxel as cycles of treatment. This means you have the drugs and then a rest to let your body ...

Immuneering Corp. (IMRX) announced positive initial response data from the first five patients treated with IMM-1-104 in combination ...

The phase IIa portion, from which the latest data was announced, is evaluating the 320mg dose of IMM-1-104 as a monotherapy ...

Tell your doctor if you are pregnant or plan to become pregnant. You should not become pregnant while using gemcitabine. Gemcitabine may harm an unborn baby. Your doctor should order a pregnancy ...

Aethlon's Hemopurifier® is a clinical stage immunotherapeutic device designed to combat cancer. Read the full article at Investorideas.com According to News-Medical.net, "Immunotherapy, which works ...

In patients with stable disease following nab-paclitaxel (Abraxane) plus gemcitabine induction, investigators observed no significant difference in overall survival for those who continued on the ...

Immuneering Corporation (NASDAQ:IMRX) released initial response data from the first five patients treated with IMM-1-104 in ...